
ELECTROMED INC
ELMDNYSE AMERICANTrading Snapshot
- Day Range
- $42.13 β $42.90
- 52-Week Range
- $18.81 β $47.40
- Volume
- $2.05B
- Avg Volume
- $2.12B
- Shares Outstanding
- 8.3M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $64M
- Last Q Revenue
- $19M
- P/E Ratio
- 34.8
- P/S Ratio
- 4.9x
- EPS (TTM)
- $1.23
- Dividend Yield
- 0.00%
Why Investors Own ELMD
- βHigh-growth profile β revenue up +49.3% YoY with expanding US Equity exposure.
- βHealthy economics β 61% gross margin and 18% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ELECTROMED INC
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates
ELECTROMED INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ELMD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ELECTROMED INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.